SemmesWeinsteini

SemmesWeinsteini is a term that is not widely recognized as a standard medical name. In most sources, the closest and more common designation is the Semmes-Weinstein monofilament, a standardized tool used to assess tactile sensory thresholds. The form SemmesWeinsteini may appear as a variant or informal reference, but authoritative medical literature typically uses Semmes-Weinstein monofilaments.

The Semmes-Weinstein monofilaments consist of a set of calibrated nylon filaments. Each filament is designed to bend at a specific force when pressed perpendicular to the skin. Filaments cover a wide range of forces, from very light to several hundred grams, enabling clinicians to gauge the patient’s cutaneous sensitivity. In practice, a filament is applied to predefined skin sites (commonly on the plantar surface of the foot and toes) until it bends, with brief, controlled contact. Testing proceeds with successive filaments until the patient can detect the stimulus. The lowest detectable force is recorded, providing an objective measure of tactile threshold and sensory loss.

History and use: The method was developed in the mid-20th century by Samuel B. Semmes and colleagues (often cited as Semmes and Weinstein) to quantify sensation and monitor neuropathy, particularly in diabetes. Today, Semmes-Weinstein monofilaments are widely used in podiatry, neurology, and rehabilitation to screen for peripheral neuropathy, guide interventions, and track changes over time.

Limitations and reliability: Results depend on examiner technique, patient attention, and skin conditions; consistent training and standardized protocols are important for reliable results.

See also: Von Frey filaments, tactile sensation, diabetic neuropathy.